›› 2012, Vol. 32 ›› Issue (8): 1092-.doi: 10.3969/j.issn.1674-8115.2012.08.028

• Review • Previous Articles     Next Articles

Research progress of intravenous immunoglobulin application in renal transplantation

ZHAN Jia-ming, WANG Xiang-hui   

  1. Kidney Transplantation Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China
  • Online:2012-08-28 Published:2012-08-29
  • Supported by:

    Foundation of International Communication and Cooperation of the Ministry of Health of China, IHECC07-001；Shanghai Science and Tecnology Committee Foundation, 10DZ2212000

PDF (PC)

1273

Abstract:

The intravenous immunoglobulin (IVIG) application in renal transplantation is divided into two aspects, immunoregulation of inflammation and immune replacement therapy. The former is mainly used for the desensitization therapy, treatment of antibody-mediated rejection and treatment of steroid-resistant rejection, and the latter is mainly used for the prevention and treatment of hypogammaglobulinemia and infectious complications after renal transplantation. IVIG not only can prevent infection through sterile immunity, but can effectively regulate immune function as well. IVIG is bound to play an increasingly important role in the improvement of prognosis of clinical renal transplantation as its unique feature.

Key words: intravenous immunoglobulin, renal transplantation, immunoregulation, desensitization protocol, rejection, hypogammaglobulinemia, infection